Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oliceridine fumarate + remimazolam vs sufentanil + remimazolam for painless abortion
ChiCTR2600119339Phase 4Recruiting
- Sponsor
- Sichuan Jinxin Xinan Women and Children Hospital
- Start
- Feb 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of oliceridine, sufentanil and remimazolam in Induced Abortion (TOP) (2 arms), sponsored by Sichuan Jinxin Xinan Women and Children Hospital. Primary endpoint: VAS score. Started Feb 2026; status: recruiting.
02
Drugs
oliceridinesufentanilremimazolam
03
Conditions
Induced Abortion (TOP)
Beyond the preview
Go deeper on ChiCTR2600119339.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600119339.